DS

Deepak Sanjay Gangavane

Active Director Director DIN 09458066
DIN 09458066 First appointment Jan 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Deepak Sanjay Gangavane

Data last updated:

Deepak Sanjay Gangavane is a Director at Saimauli Hospitals Private Limited (since 2022). The company operates in Healthcare.

DIN 09458066
Primary Designation Director
Industry Healthcare
First Appointment 05 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saimauli Hospitals Private Limited U85100PN2022PTC207436
Director05 Jan 20222022Active

Board colleagues of Deepak Sanjay Gangavane

NameDINCompanyDesignation
Sagar Somnath Pawar09051782Saimauli Hospitals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Saimauli Hospitals Private Limited
Premium access

Shareholding and investment profile for Deepak Sanjay Gangavane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak Sanjay Gangavane

Deepak Sanjay Gangavane currently holds 1 directorship: Saimauli Hospitals Private Limited (Director, since 05 Jan 2022).

Deepak Sanjay Gangavane was first appointed on 05 Jan 2022 as Director at Saimauli Hospitals Private Limited.

The current boards of Deepak Sanjay Gangavane's companies include Sagar Somnath Pawar (Saimauli Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available